24th February 2023 - St Luke's Radiation Oncology Network is pleased to announce the appointment of Prof Charles Gillham as the new Network Director. Prof Gillham takes up the post having been a Consultant Radiation Oncologist in St Luke's Radiation Oncology Network for 15 years and the Clinical Lead at St Luke’s Centre at St James Hospital since 2013.
Prof Gillham sub-specialises in the radiotherapy treatment of sarcomas, gynaecological, colorectal and haematological malignancies. He is the National Lead for Sarcoma, co-founder of the Irish Sarcoma Group, an active member of Cancer Trials Ireland and since 2015 has been the Chief Examiner in Radiation Oncology for the Faculty of Radiology, Royal College of Surgeons in Ireland.
Trevor O'Callaghan, Chief Executive Officer of the Dublin Midlands Hospital Group commented: “I am delighted to welcome Prof Gillham as the new Network Director of St Luke's Radiation Oncology Network, a leader in cancer treatment, patient care, research and education. Charles is committed to driving key priorities that improve the working environment for staff and the patient experience. I look forward to working with him and the team throughout the St Lukes Radiation Oncology Network to continue driving key priorities for the provision of an optimised cancer service for our patients."
Prof Charles Gillham, Network Director, St Luke's Radiation Oncology Network stated: “It is with great pleasure that I take up this new role as Network Director of the largest radiation oncology centre in Ireland at such an important time in healthcare. The Irish healthcare system is still recovering from the enormous impact of the pandemic and the cyberattack in 2021 with residual systemic challenges. SLRON launched its first-ever strategy last year with a focus on ensuring the finest cancer workforce and a commitment to research and technological innovation to provide the best possible care for patients. I look forward to implementing this ambitious plan for further development in optimised cancer care, underpinned by patient experience. My key priorities will be focused on patients, staff and education and to build on St Luke’s exemplary history of innovation, research, education and quality cancer service.”
